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Resuscitation in Covid-19 
Abstract 
Covid-19 is a complex disease which has challenged the way in which care is provided. 
Cardiopulmonary resuscitation (CPR) is recognised as a potential aerosol-generating procedure, in 
consequence, a modified advanced life support approach needs to be followed. This article describes 
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Key points 
 Patients with severe Covid-19 disease can rapidly deteriorate, Early Warning Scoring tools may 
not be sensitive enough to detect deterioration.  
 Cardio-respiratory arrest in patients with suspected or confirmed Covid-19 requires a 
modified approach to resuscitation. 
 During the pandemic, hospitals have had to respond to increased numbers of cardiac arrests 
due to patients with severe Covid-19 disease, in consequence, staff involved in incidents must 
have access to structured de-briefing and to support.  
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Resuscitation is arguably one of the most physically and mentally challenging tasks that a healthcare 
professional can undertake. Patients admitted due to COVID-19 have an increased propensity for 
rapidly progressive respiratory failure, necessitating critical care admission [1], and it is essential that 
early consideration should be made for advanced care planning. It is important to establish with the 
patient and the people that are important to them what treatments are likely to be of benefit. This 
includes discussing the implications of critical care admission and resuscitative treatment. Therefore, 
this article focusses on the impact of the additional stressors and challenges that must be considered 
when delivering resuscitative treatment during the COVID-19 pandemic. It reviews the evidence and 
guidance that has been developed to help health care professionals carry out resuscitation for patients 
in the presence of the clinical  symptoms of Covid-19. It also explains practical application of the 
guidance developed in the context of usual and expanded critical care environments 
Before carrying out resuscitation, there are some important factors that all teams need to be aware 
of, as they may vary according to the clinical environment. As many ward and specialist settings have 
been reconfigured or expanded due to the pandemic, carrying out in situ simulation of cardiac arrests 
can be of benefit to teams. These enable staff to practice and familiarize themselves with the non-
technical skills and equipment unique to this situation and through this can contribute to improving 
patient outcomes [2].  Teams can check all staff are aware of where level 3 personal protective 
equipment (PPE) is kept, who the Team leader will be if there is a cardiac arrest, what other team roles 
need to be assigned, and how the Cardiac Arrest team is summoned. Information can be shared 
regarding where the cardiac arrest equipment is kept and its layout.  Should any members not know 
how to use the equipment (e.g. defibrillator) appropriate training can be given before an actual clinical 
incident arises. During the pandemic the re-deployment of staff has made need for re-training much 
more frequent, and it is recommended that skills assessments are made when staff move to a new, 
and possibly very different, clinical environment. 
It is a cause for concern that in some settings contradictory advice has been given. For example, in the 
UK, both the International Liaison Committee on Resuscitation and Resuscitation Council (UK) [3, 4] 
identify cardio-pulmonary resuscitation (CPR) as an aerosol generating procedure (AGP), yet this was 
not reflected in Public Health England guidance which deemed CPR not to be an AGP [5].  As a result, 
at local level, hospitals have implemented and adapted their own specific algorithms, for example, all 
inpatients are considered Covid-19 suspected regardless of reason for admission [6]. In consequence, 





Advanced Care Planning 
Advanced care planning is key to efficient care delivery, therefore nurses need to know the 
documentation used and understand the legal and clinical implications of the decisions made. A Do 
Not Attempt Cardio-Pulmonary Resuscitation (DNA-CPR) order is a legal document.  However, some 
clinicians and the general public have a perception that this also dictates the level of treatment that a 
patient receives, seeing it as the clinical equivalence of ‘giving up’ [7], this is not true. While it does 
specify that cardiopulmonary resuscitation (CPR) will not be initiated if a patient does suffer cardiac 
arrest, it does not dictate the ‘ceilings of care’ for the patient, or dictate whether the patient should 
be admitted to Critical care. The setting and timing of the discussions needed for advanced care 
planning should also be carefully considered [8]. There are legal considerations to the discussion of 
DNA-CPR orders. To prevent misunderstandings and mis-communication the BMA, RCN and RC (UK) 
have all sought to clarify the current legal and ethical considerations of this process through the 
publication of a joint statement [9]. Nursing professional organisations have also published further 
guidance emphasizing the need for an individualized, patient-centered approach to this process during 
the current pandemic [10]. 
Treatment Escalation Plans are becoming more commonplace in acute healthcare settings. These set 
out clearly for members of the multidisciplinary team what interventions the clinical team, in 
discussion with the patient/next of kin have decided would be appropriate should the patient 
deteriorate. This may include whether the patient should be admitted to critical care or receive Non-
Invasive Ventilation (NIV). These plans are beneficial if they are made prior to deterioration  as they 
provide the opportunity for the patient and their next of kin to ask questions and to have the 
risks/benefits and rationale of the decisions being made, explained to them. This can also be an 
opportunity for practitioners to discuss the current prognosis and expected clinical course. To support 
clear documentation of all aspects of decisions made, several organizations have collaborated to form 
the Respect process [11] which provides resources to support these conversations and a standardized 
format of documentation to accompany the shared discussions. 
Professional and Patient Safety 
The International Liaison Committee on Resuscitation (ILCOR) state that chest compressions have the 
potential to generate aerosols and recommends that healthcare professionals should wear 
appropriate PPE for resuscitation attempts [4] . The Aerosol Generating Procedures (AGPs) essential 
to Advanced Life Support (ALS) represent a hazard of contamination and infection to anyone in the 
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immediate vicinity as droplets are expelled from the patient into the area around them. In some 
clinical areas, such as critical care,  where the nature of care services provided means there are already 
AGPs ongoing, team members may already be wearing the appropriate PPE for resuscitation. This 
should lead to reducing delay in commencing chest compressions. 
It has to be accepted that in this current pandemic, there are situations where the team may not be 
wearing full PPE, and consequentially will not be in an appropriate state of preparedness to 
immediately start chest compressions. Therefore, to minimise delays, in areas where there is a 
possibility of sudden presentation of possible or confirmed COVID-19 cases, such as the Emergency 
Department, full PPE should be readily available and accessible, with all practitioners aware of its 
location. 
After a cardiac arrest has been recognized, during the Covid-19 pandemic there needs to be a careful 
balance between risks versus benefit. It is essential to ensure that there are sufficient team members 
with an appropriate skill-mix for the attempt, whilst minimizing exposure to AGPs by restricting staff 
in the environment to those essential for the resuscitation attempt [2]. RC (UK) also advises placing a 
simple oxygen mask on the patient’s face, to limit the dispersal of contaminated droplets [2]. During 
resuscitation attempts this may pose an increased risk of transmission of Covid-19 to responders and 
other patients within the vicinity [12]. This is an important consideration, because previous infectious 
disease outbreaks have shown the transmission of viruses to health care professional despite them 
wearing PPE during resuscitation attempts [13, 14].   
Recognition of the Deteriorating Patient 
Individuals with severe Covid-19 disease may develop respiratory failure without accompanying 
circulatory failure. They can deteriorate rapidly, with the unique feature of requiring a sudden increase 
in oxygen requirements without significant changes to other parameters and symptoms of respiratory 
distress. Early Warning Scoring tools may not be sensitive enough to detect such changes [15]. In 
consequence, this may impact on recognition of the deteriorating patient and the team response to 
clinical deterioration.  
The decision to initiate resuscitation during a pandemic is complex. In some settings it has been 
proposed that CPR should not be initiated without adequate PPE [16]. In the early phase of the UK 
pandemic, reports of restrictive resuscitation practices include the recommendation that patients in 
cardiac arrest outside the emergency department can only be given defibrillator treatment if they 
have a “shockable” rhythm [17]. While these practices have been condemned as they do not follow 
national or international guidance, nevertheless they will have impacted on patient survival rates. 
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Therefore, hospitals must have appropriate plans in place for the management of the deteriorating 
patient for all cardiac arrest situations.  
 
Recognition of Cardiac Arrest 
Prior to the COVID-19 pandemic a ‘Look, Listen, Feel’ detection method was advised [18], whereby 
the practitioner would bring their face close the patient’s mouth to recognize cardiac arrest. In the 
presence or possibility of COVID-19 this method has considerable potential for contamination and/or 
infection of the practitioner. In consequence, the guidelines have been updated, and now recommend 
that the practitioner still performs the look listen and feel detection, but  stands further distanced 
from the patient’s face [2] and for no longer than 10 seconds. If the patient’s breathing is absent or 
abnormal (agonal gasping), then chest compressions should be initiated. 
Manual pulse palpation at the carotid can be performed if you have been trained to do so. However, 
there is now some documented evidence of false positives/negatives arising during manual pulse 
palpation [19].  Therefore, if the practitioner has not be trained in this technique, confirmation of 
cardiac arrest should be specified as above by solely checking for ‘normal breathing’. 
Calling for help 
Activation of the cardiac arrest team should be the first consideration after confirmation of a cardiac 
arrest. The process for this can differs as it tends to be based on local guidelines. Clinical areas such as 
Critical Care or the Emergency Department may manage cardiac arrests ‘internally’ whilst most ward 
environments will call for the cardiac arrest team via a telephone/bleep system. All staff need to be 
fully orientated to local guidelines and all communication should make it clear when and if there is a 
potential risk of COVID-19 infection. 
Assessment of Rhythm 
Consideration should be made for early application of an automated external defibrillator (AED) or 
manual defibrillator to determine the patient’s cardiac arrest rhythm. Previously chest compressions 
would have been immediately initiated after confirmation of cardiac arrest, but the change in 
approach has been made because this intervention is thought to produce additional aerosolized 
droplets, increasing the potential for contamination and/or disease transmission. The benefit of a 
‘defibrillator-first’ approach is that it can be carried out whilst other team members don PPE and 
prepare to provide chest compressions. Once the defibrillation pads are applied to the patient, rhythm 
assessment can take place.  
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Today, many In-hospital defibrillators have an AED mode. This enables the machine to automatically 
detect the cardiac rhythm of the patient and recommend the appropriate treatment strategy 
(Shockable or Non-Shockable). When using the AED mode, it is important to follow all cues the 
machine provides to ensure correct rhythm analysis, as continuing CPR during this process can in some 
instances lead to inappropriate treatment. The risk/benefit of using the defibrillator in AED mode is 
complex. It is possible that the AED mode can decrease the time to first defibrillation attempt (12). 
However, there is an argument that using manual mode can decrease ‘pre-shock pauses’ and in doing 
so can theoretically improve the chances of achieving return of spontaneous circulation (ROSC) (13). 
Nevertheless, those that have only been trained to use the AED mode, should avoid the use of the 
manual mode. This requires additional training, as it needs rapid identification of cardiac arrest 
rhythms, and a good understanding of the safe defibrillation sequence. 
Throughout ALS the cardiac arrest rhythm is re-assessed every two minutes and treatment 
administered as per the appropriate branch of the algorithm. As previously highlighted; chest 
compressions generate ECG artifacts that can lead to misinterpretation of the cardiac arrest rhythm. 
Therefore, CPR needs to be paused to enable effective analysis of the rhythm to be made.  As with 
any interruption in chest compressions, this pause should be minimized and take no longer than five 
seconds [20]. If the defibrillator is being used in manual mode, then the team leader should have a 
good view of the defibrillator screen prior to pausing CPR. 
There are four classifications of cardiac arrest rhythm. The Resuscitation Council (UK) (RC (UK)) has 
produced guidance and an algorithm to maximize the effectiveness for resuscitation in the context of 
COVID-19 [2]. The management of these is separated into two branches of the algorithm - Shockable 
and Non-Shockable.  
Non-shockable rhythms 
Non-shockable rhythms include pulseless electrical activity (PEA) and asystole.  PEA is a rhythm that 
would be compatible with life, and therefore a member of the team should attempt to palpate a 
carotid pulse if this is seen. If there is insufficient cardiac output to generate a pulse, CPR should be 
recommenced. Asystole can be characterized as a ‘flat’ line, although typically there may be some 
small amounts of drift. It is indicative of an absence of mechanical and electrical cardiac activity. Once 
a non-shockable rhythm has been identified, CPR should be immediately re-initiated. 
Shockable rhythms 
Cardiac arrest rhythms which can be restored by defibrillation, include pulseless Ventricular 
Tachycardia (pVT) and Ventricular fibrillation (VF). pVT is characterized as a tachycardia, with regular 
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broad QRS complexes. VF can be recognized as a disorganized irregular rhythm, with no discernible P, 
Q, R, S, T waves. This is due to random twitching and electrical activity across the muscle fibers of the 
heart.  
Defibrillation 
If the patient is in a shockable rhythm, early defibrillation is associated with a greater likelihood of 
ROSC [21]. RC (UK) recommends that whilst the defibrillator is charging, CPR is recommenced with all 
other team members (other than the CPR provider) instructed to stand clear. Once the defibrillator is 
charged the CPR provider should also be instructed to stand clear, the shock administered, and CPR 
immediately recommenced [18]. If, as per the modified COVID-19 algorithm, the defibrillator has been 
attached prior to CPR and the patient is in a shockable rhythm; up to three shocks can be administered 
in an attempt to convert the patient to a rhythm compatible with life whilst awaiting others to 
commence chest compressions. 
It is vital that safety is maintained throughout any defibrillation attempt. Due attention must be made 
to the area within which the shock is being administered. No-one should be in contact with the patient 
or their immediate area, this prevents any risk of shock transference, which could potentially harm 
team members.  
There are some concerns around the perceived risk of ignition caused by defibrillation due to the 
presence of oxygen. The European Resuscitation Council (ERC) reports that there is no evidence of this 
occurring when self-adhesive pads were used. ERC advises that practitioners exercise caution when 
performing defibrillation, ensuring that direct sources of oxygen such as a mask or nasal cannula be 
removed to one meter away from the patient. Also that a ventilation bag should remain attached to 
an ETT or SGA during shock delivery [20]. In critical care, patients may be ventilated, during CPR to 
prevent disconnection of the ventilator, a mandatory mode of ventilation with a set respiratory rate 
of 12 breaths per minute and a FiO2 of 1.0 can be set. If disconnection from the ventilator is required, 
the ventilator should be placed into the stand-by mode, to prevent aerosolisation of particles. During 
defibrillation, the charge should be delivered during expiration to prevent transthoracic impedance.   
Chest Compressions 
Chest compressions should be delivered at a rate of 100-120 compressions per minute, vertically to a 
depth of 5-6Cm (or a third of the anterior-posterior depth of the patient’s chest). Chest compression 
should be delivered with the heel of the practitioner’s hand in the center of the low half of the 
patient’s sternum [22].  Since the onset of the pandemic, patients with severe Covid-19 who are 
unstable have been observed to deteriorate, resulting in cardiac arrest while in the prone position, as 
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this has been increasingly used to improve oxygenation for both intubated and conscious patients 
with COVID-19 [23. 24]. Returning a patient to the supine position is the optimum for resuscitation. 
However, as this necessitates a coordinated team procedure, particularly for a patient that is 
intubated, it may not be immediately possible. In consequence, CPR can be commenced in the prone 
position. The Intensive Care Society has highlighted that there is limited evidence available regarding 
this, but recommends a two-handed technique between the scapula [25]. The ERC also endorse this 
technique, recommending a similar rate and depth as supine (usual) CPR [26].  It has to be noted that 
applying sternal counter-pressure may help to generate higher Mean Arterial Pressures (MAP) [27] 
Consistent quality of chest compressions is positively associated with ROSC [28] ; however, provision 
of effective chest compressions is physically tiring, and in this pandemic providers are also 
encumbered by PPE and thus are likely tire sooner. As the provider tires there will be drop off in overall 
quality of chest compressions. Swapping providers often to maintain efficacy of chest compressions is 
an easy means of negating this. Therefore, team members need to monitor the quality of chest 
compressions. This can be achieved visually, using a metronome or using CPR feedback devices where 
available, or a diminishing EtCO2 trace can be another indicator of compression provider fatigue. In 
Covid-19 areas, the number of responders may be limited due to availability of staff and those who 
are wearing appropriate CPR. In consequence, teams may need to swap providers more frequently 
and rotate all team members (excluding the team leader) to perform CPR.  
Throughout the resuscitation attempt any interruption in CPR should be no greater than 5 seconds. 
This is due to the rapid drop-off in perfusion pressure when there is no CPR. In order to minimize the 
interruption when swapping CPR providers, it should be clearly established and stated, as to who will 
be taking over, and a clear countdown should be given “3…2…1”. To further minimize interruptions in 
CPR these changeovers should, where possible, be integrated with the necessary pauses for rhythm 
assessment [20]. 
In some settings mechanical chest compression devices may be available. These devices perform chest 
compressions at a set rate, particularly useful for prolonged cardiac arrests where team member 
fatigue becomes a significant risk to chest compression quality. It is important to recognize that as 
with all medical equipment, these devices require specific training to ensure they are applied 
appropriately and effectively. In addition, in the Covid-19 environment, equipment may not be 





If the patient has an existing intravenous (IV) access this should be assessed for patency. If this is 
insufficient or not patent, further access should be gained to enable the administration of drugs and 
fluids. The peripheral IV cannula is the equipment most healthcare professionals will be familiar with, 
so inserting wide-bore cannula bilaterally may be the most readily available means to gain IV access, 
however, in the absence of cardiac output the patients vasculature will peripherally shut down making 
this more challenging. 
Intraosseous (IO) access is a good alternative to traditional vascular access with equipment available 
in many in-hospital environments. The correct insertion technique for these devices requires 
additional training, however there are several benefits to using IO during cardiac arrest. For a trained 
practitioner, the landmarking and insertion process can be faster than typical Central Venous Catheter 
(CVC) placement [29] .  Evidence has shown that medications can take as little as three seconds to 
reach the heart via the humeral head intraosseous route, demonstrating its viability for resuscitative 
purposes [30]. However, there are several contra-indications to intraosseous access including the 
presence of any hardware/trauma in the limb and recent attempted/successful previous IO insertion. 
CVC or central lines are typically established in critical care patients. It is important to account for the 
additional dead space in these lines, therefore, flushing with an appropriate volume of 0.9% Sodium 
chloride is required so that the entire dose is administered. 
Drugs 
During cardiac arrest it may be appropriate to administer drugs, depending on the rhythm, timing and 
cause of the cardiac arrest. Adrenaline (Epinephrine) (1mg) [31] has been given historically in cardiac 
arrest due to its alpha-adrenergic vaso constrictive effects which increase cerebral and coronary 
perfusion [20]. It is administered in both the shockable and non-shockable algorithm but is dependent 
on the initial cardiac arrest rhythm [20]. In non-shockable rhythm, Adrenaline (Epinephrine) is 
administered immediately, and subsequent doses should continue to be administered every 3-5 
minutes. Practically speaking this would be after every alternate rhythm assessment, at four-minute 
intervals.  
If the initial rhythm is shockable, then this adrenaline regime should only be initiated after the third 
shock has been administered. If the patient converts to a non-shockable rhythm, then the adrenaline 
regime is commenced. Once the adrenaline regime has commenced it continues irrespective of 
subsequent cardiac arrest rhythms. 
Amiodarone is an anti-arrhythmic drug that slows atrioventricular conduction and appears to improve 
response to defibrillation [20]. It is administered if the patient is in a shockable rhythm, this should be 
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administered after the third shock [32]. After a fifth shock a further dose of 150mg should be 
considered [20].  There are ongoing clinical studies for both medications and their impact on cardiac 
arrest outcomes and guidelines may be updated in the future dependent on quality and significance 
of evidence. 
Airway Management 
Placement of an advanced airway allows for continuous (asynchronous chest compressions). This 
should be done by a practitioner who is experienced and competent in airway management. Ideally, 
the patient will be intubated using an endo-tracheal tube (ETT), however a supraglottic airway (SGA) 
such as an iGel or LMA may be used. To minimize risk of exposure to team members a viral filter should 
be integrated into the airway circuit [26].  Once the airway is secured the patients ventilation will need 
to be continuously monitored to ensure adequate oxygenation. This can be done in three ways by 
visually by confirming bilateral chest movement, by auscultation of the chest to confirm bilateral air 
entry and via End-tidal CO2 (ETCO2) monitoring. However, in Covid-19 it may not be possible to 
auscultate the chest due to PPE and the risk of breaching PPE. In consequence, other methods may be 
relied upon. ETCO2 waveform monitoring also has other applications for cardiac arrest management. 
Interpreting the values and waveforms generated during the resuscitation attempt, can be indicative 
of quality of CPR, prognostication and ROSC [33-35].  
Reversible causes and etiology 
As management of the cardiac arrest proceeds from basic to ALS any potentially reversible causes of 
the cardiac arrest should be considered and addressed. These are often described as the four ‘H’s and 
T’s’ [20]. ‘H’s include hypoxia, hypovolaemia, hypo/hyperkalaemia (including metabolic disorders) and 
hypothermia. ‘T’s include tension pneumothorax, tamponade, toxins and thrombosis. The aim of 
resuscitation is to restore spontaneous circulation as soon as possible, therefore those factors most 
likely to be contributing to the cardiac arrest should be addressed first. Key to this process is 
understanding the potential etiology of cardiac arrest in the context of COVID-19. In the presence of 
COVID-19 infection hypoxemia secondary to Acute Respiratory Distress Syndrome (ARDS) is a 
potential causative factor of cardiac arrest. Consequentially an early consideration should be made to 
ensure hypoxia is effectively and definitively countered with advanced airway management, and 
manually ventilated with a high concentration of oxygen [26]. 
There is some evidence to suggest COVID-19 severity is associated with electrolyte imbalance, 
specifically sodium, potassium and calcium deficiencies [36]. There is also growing evidence of acute 
kidney injury in COVID-19 patients requiring Renal Replacement Therapy (RRT) [37]. Significant 
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electrolyte derangement is associated with increased risk of sudden cardiac arrest [38].  As a 
constituent of effective cardiac arrest management electrolytes should be checked using a rapid point-
of-care test, typically an Arterial Blood Gas (ABG) sample, to detect any electrolyte imbalance. This 
should then be corrected appropriately.  
The evidence of increased risk of acute kidney injury in COVID-19 patients (31) has been partially 
attributed to hypovolemia, secondary to fever and dehydration common in this patient group [39]. 
This can be corrected intra-arrest with crystalloid intravenous fluids such as 0.9% sodium chloride or 
Hartmann’s solution in boluses [20].  
Hypothermia is unlikely in the context of in-hospital COVID-19 patients but should be ruled out for 
patients arriving as Out-of-Hospital-Cardiac Arrests (OHCAs). This can be corrected with warmed IV 
fluid infusion and external warm air [38].  
Emerging evidence has suggested there has been an increased incidence of thromboembolic events 
in COVID-19 patients [40]. In the context of cardiac arrest, the treatment for this is fibrinolytic drugs. 
Once fibrinolytic drugs have been administered resuscitation may continue for 60-90 minutes in order 
to ensure that this medication can break down any potential thrombus [38].  
COVID-19 patients are often intubated due to ARDS and consequentially can have poor lung 
compliance undergo sustained periods of ventilation. These are known risk factors for pneumothorax 
formation [41]. A multicentre case series has also demonstrated these patients are more prone to 
pneumothoraxes [42]. A pneumothorax can be detected by observing the chest for asymmetrical chest 
movement and auscultating for asymmetrical poor or absent air entry. If there is an ETT in situ, then 
unintentional endobronchial intubation is a possible differential diagnosis. Tracheal deviation is 
another indication of tension pneumothorax; however, this is a late sign, therefore the team should 
not wait to observe this prior to initiating treatment. The initial treatment for a tension pneumothorax 
is a needle thoracentesis (decompression). Historically this would be performed using a wide bore 
cannula in the second intercostal space, midclavicular line. There is now evidence to suggest that 
performing this in the fifth intercostal space on the mid-axillary line has a higher success rate [43]. A 
tension pneumothorax must be definitively treated by inserting an underwater sealed chest drain or 
by thoracostomy [38]. 
Cardiac tamponade can be difficult to detect intra-arrest and will likely only be present with an 
indicative history such as chest trauma or recent cardiac surgery. Use of ultrasound intra-arrest can 
be used to diagnose this, however this should only be attempted by trained clinicians to avoid 
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prolonged interruption to chest compressions [20]. If this is detected then a resuscitative thoracotomy 
would be indicated.  
Where there is evidence of toxic or therapeutic substances contributing to the cardiac arrest, expert 
help via online databases or poison centers should be sought to administer the appropriate antidote 
where possible [38]. Prolonged resuscitation may be required if this may enable the excretion or 
metabolization of a causative toxin or for an antidote to take effect [38]. 
Communication 
Co-ordination of the multi-disciplinary team during a cardiac arrest is pivotal to ensuring that 
interventions are enacted promptly as the situation develops. The use of PPE will impact the 
identification of team members and communication. A popular means of overcoming this has been to 
write names/roles in large lettering on the front of PPE, being mindful to not compromise these 
protective barriers. As team members will be wearing PPE this will lead to vocal muffling and the loss 
of lip-reading ability and other non-verbal facial communication cues. Teams should be aware of this 
negative factor and be mindful of unnecessary noise and the flow of communication during the 
resuscitation attempt. Use of closed loop communication has been demonstrated to improve this [44]. 
Establishing and using gestures and other non-verbal communication tools with colleagues may also 
be helpful. 
Termination of attempt 
As the situation develops and after potentially reversible causes of the cardiac arrest have been 
addressed, the team should consider the potential success of this resuscitation attempt. The ERC 
states that “Asystole for more than 20 min during ALS in the absence of a reversible cause is generally 
accepted as an indication to abandon further resuscitation attempts. However, there are reports of 
exceptional cases that do not support the general rule, and each case must be assessed individually” 
[45].  The termination of a resuscitation attempt can be challenging. The decision ultimately rests with 
the team leader, however there may be a benefit to asking others involved in the resuscitation 
attempt if they have any concerns/treatments to suggest prior to discontinuing (43) 
The evidence gathering related to in-hospital cardiac arrest outcomes for COVID-19 patients is 
ongoing. Current studies have demonstrated outcomes for COVID-19 positive cardiac arrest cases 
range from 13.2% to 42% ROSC rate [47-48], with one study in Wuhan, China reporting a 2.9% survival 




If the patient shows any signs of life/a pulse, then post-resuscitative care should begin. As soon as 
ROSC is confirmed the team around the patient should then co-ordinate assessment using an airway, 
breathing, circulation, disability and exposure (A, B, C, and D, E) systematic approach.  The airway is 
assessed to ascertain if the patient is tolerating any airway interventions and are they still effective? 
If this is an SGA or ETT this can be confirmed by the same means as set out above. Sedation and 
analgesia infusions may need to be initiated in order for the airway device to be tolerated. In Covid-
19 areas it may not be possible to confirm air entry. However, an ABG should be taken to confirm 
effective gas exchange and detect any respiratory failure. Determining SpO2 using a peripheral sensor 
may not be immediately possible due to the patient’s poor perfusion state. In the critical care 
environment consider if the patient can now be connected to a ventilator and further optimized. It is 
advisable to perform a chest x-ray as part of post-resuscitative care to detect any potential chest 
resuscitation related injury such as a pneumothorax and confirm the placement of any medical devices 
such as an ETT [49].  
Post cardiac arrest, patients may be cardiovascularly unstable. Therefore, patients should be assessed 
to confirm that the patient does not require further intervention due to cardiac arrythmias in order to 
prevent re-arrest. If the patient is unstable then it may be of benefit for one member of the team to 
maintain a position palpating the carotid pulse, in case the patient deteriorates into a PEA, as cardiac 
monitoring would continue to show a rhythm compatible with life in this case. A 12 lead ECG should 
be taken, in order to detect cardiac arrythmias, heart blocks or myocardial ischemia that may have 
contributed to the cardiac arrest.  
A neurological assessment of the patient should take place to assess the patient post-arrest. This 
should include a Glasgow Coma Scale score and pupillary reflexes. More advanced neurological 
assessment including imaging may be required and contribute to prognostication [50].  
The ERC advises the avoidance of hyperthermia in the post-arrest period, which can be common in 
the first 48 hours [50]. This can be achieved via several methods include active cooling pads and 
antipyretics. There is additionally ongoing evidence gathering around the process of Targeted 
Temperature Management (TTM) and the optimal maintenance temperature that may positively 
impact neurological recovery post-ROSC [50].  
Equipment 
All surfaces and equipment involved in the cardiac arrest should be decontaminated or disposed of 
appropriately and as per manufacturer guidance, particularly those associated with airway 




There are often practical learning points to be taken away from a resuscitation attempt. Sharing these 
as a team after the event gives an opportunity to highlight any concerns they have, or anything they 
thought went well and should be replicated. This can contribute to improved patient outcomes [52]. 
There are various models that have been developed for debriefing. A debrief can be as simple as 
thanking team members for their work and asking if they have any immediate questions or concerns 
about the event. The level of sudden deterioration and mortality during the pandemic is of a scale 
unseen by many healthcare professionals. Team members may feel that they benefit psychologically 
from debriefing [53]. Acute healthcare settings should ensure that anyone exposed to a resuscitative 
event has access to psychological support. 
Conclusion 
There are several alterations to typical resuscitation practice that healthcare professionals should be 
aware of as they deliver care during the pandemic. Effective dissemination of these adjustments 
alongside preparation of teams and environments will benefit resuscitation attempts. The causative 
factors of cardiac arrest in COVID-19 and the outcomes for these patients are the topic of ongoing 
research, and so there is a need for practitioners to continuously update themselves, enabling them 
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